The transcriptional and regulatory identity of erythropoietin producing cells

Bjørt K. Kragesteen*, Amir Giladi, Eyal David, Shahar Halevi, Laufey Geirsdóttir, Olga M. Lempke, Baoguo Li, Andreas M. Bapst, Ken Xie, Yonatan Katzenelenbogen, Sophie L. Dahl, Fadi Sheban, Anna Gurevich-Shapiro, Mor Zada, Truong San Phan, Roberto Avellino, Shuang-Yin Wang, Oren Barboy, Shir Shlomi-Loubaton, Sandra WinningPhilipp P. Markwerth, Snir Dekalo, Hadas Keren-Shaul, Merav Kedmi, Martin Sikora, Joachim Fandrey, Thorfinn S. Korneliussen, Josef T. Prchal, Barak Rosenzweig, Vladimir Yutkin, Fernando Racimo, Eske Willerslev, Chamutal Gur, Roland H. Wenger, Ido Amit

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

33 Citationer (Scopus)

Abstract

Erythropoietin (Epo) is the master regulator of erythropoiesis and oxygen homeostasis. Despite its physiological importance, the molecular and genomic contexts of the cells responsible for renal Epo production remain unclear, limiting more-effective therapies for anemia. Here, we performed single-cell RNA and transposase-accessible chromatin (ATAC) sequencing of an Epo reporter mouse to molecularly identify Epo-producing cells under hypoxic conditions. Our data indicate that a distinct population of kidney stroma, which we term Norn cells, is the major source of endocrine Epo production in mice. We use these datasets to identify the markers, signaling pathways and transcriptional circuits characteristic of Norn cells. Using single-cell RNA sequencing and RNA in situ hybridization in human kidney tissues, we further provide evidence that this cell population is conserved in humans. These preliminary findings open new avenues to functionally dissect EPO gene regulation in health and disease and may serve as groundwork to improve erythropoiesis-stimulating therapies.

OriginalsprogEngelsk
TidsskriftNature Medicine
Vol/bind29
Udgave nummer5
Sider (fra-til)1191-1200
ISSN1078-8956
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
We thank members of the Amit laboratory for critical discussions. We thank Y. Kuperman, L. Adler and S. Viukov for assisting with hypoxia experiments. We thank K. Pozyuchenko, G.H. Siloni, C. Padberg and T. Bajanowski for assisting with human kidney samples, and P. Spielmann and T. Knöpfel for technical support. We thank T.-M. Salame, E. Hagai and E. Kopitman for assisting with flow cytometry. This study was funded by European Union European Research Council Advanced (grant no. 101055341-TROJAN-Cell, I.A.); Deutsche Forschungsgemeinschaft (Project-ID 259373024 – TRR 167, I.A.), Israel Science Foundation (ISF; grant no. 1944/22, I.A.), the ISF Israel Precision Medicine Program (607/20, I.A.), Human Frontier Science Program (long-term postdoctoral fellow LT 000230/2019, B.K.K.), European Molecular Biology Organization (postdoctoral fellowship, ALTF 112-2022, A.G.), Villum Fonden (Young Investigator award project no. 00025300, F.R.) and by the Swiss National Science Foundation (grant no. 310030_184813 R.H.W.).

Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer Nature America, Inc.

Citationsformater